Azithromycin for oral suspension USP

Cadila Healthcare Limited

Revision date : 2018-08-04

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

57-50-1

Name of the chemical

Sucrose, pure C12H22O11

Concentration

N/A

EC/CAS

9004-64-2

Name of the chemical

hydroxypropylcellulose

Concentration

N/A

EC/CAS

11138-66-2

Name of the chemical

xanthan gum

Concentration

N/A

EC/CAS

25956-17-6

Name of the chemical

Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate (17); (CI 16035)

Concentration

N/A

General Information

Revision date

2018-08-04

Product name

Azithromycin for oral suspension USP

Chemical name

9-Deoxo-9a-aza-9a-methyl-9a-homoerythromycinAdihydrate, N-methyl-11-aza- 10-deoxo-10-dihydroerythromycin A

1.2.1 Relevant identified uses

Therapeutic Category Macrolide

1.2.2. Uses advised against

/ Contraindications Patients should not take aluminum- and magnesium- containing antacids and azithromycin simultaneously

Icons in SDS

Company Information

company name

Cadila Healthcare Limited

Section 2

SECTION 2: Hazards identification

Dose and Administration Dosage should be individualized with careful monitoring of patient response. The recommended adult dosage for Azithromycin for Oral Suspension USP 100mg/5mL and 200mg/5mL in the treatment of Acute bacterial sinusitis is 500mg once daily for 3 days. Dosing regimen should be adjusted according to each patient’s need at the discretion of the physician. Adverse Effects Most common adverse reactions are diarrhea (5 to 14%), nausea (3 to 18%), abdominal pain (3 to 7%), or vomiting (2 to 7%). Over Dose Effect Adverse reactions experienced at higher than recommended doses were similar to those seen at normal doses particularly nausea, diarrhea, and vomiting. In the event of over dosage, general symptomatic and supportive measures are indicated as required. Contraindications Azithromycin for Oral Suspension USP is contraindicated in Patients with a history of cholestatic jaundice/hepatic dysfunction associated with prior use of azithromycin. Pregnancy Comments There are no adequate or well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human

Response

azithromycin should be used during pregnancy only if clearly needed. Reproduction studies have been performed in rats and mice at doses up to moderately maternally toxic dose concentrations (i.e., 200 mg/kg/day). These daily doses in rats and mice, based on body surface area, are estimated to be 4 and 2 times, respectively, an adult daily dose of 500 mg. In the animal studies, no evidence of harm to the fetus due to azithromycin was found. Pregnancy Category Pregnancy Category B

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.